All Insights
Showing 1 - 12 of 1918
Competition, antitrust and trade
UK government sets out plans to update investment screening rules
Revised definitions across eight sectors, a water schedule and fresh carve-outs for AI end-users take shape
ESG – Environmental, Social and Governance
ESG Knowledge Update | April 2026
Welcome to Osborne Clarke's ESG Knowledge Update brought to you by our multi-disciplinary ESG team
Employment and pensions
New data protection complaint duties for UK pension trustees take effect from 19 June
Trustees have a narrow window to put processes in place
The Built Environment
English Technology and Construction Court confirms building liability orders can be secured before trial
Decision provides welcome clarity on 'just and equitable' test which is likely to influence how building safety claims are pursued
Data Centres
How investors are managing risk in the new wave of European data centre projects
Data centre investment is accelerating in Europe, with regulation, grid access and power reshaping how projects get done
Regulatory and compliance
Regulatory shifts in 2026 increase litigation risk on 'forever chemicals'
PFAS regulation is entering a critical phase, with significant developments unfolding simultaneously in the EU and the UK
Financial Services
Financial Conduct Authority launches £7.5bn UK motor finance redress scheme
Firms face tight timeline to implement scheme covering nearly two decades of lending as risk of legal challenge looms
Financial Services
Fundraising in the EU and the UK: a technical guide
International fund managers raising capital face a patchwork of national rules that is growing more complex, with the gap between
GDPR for HR
GDPR for HR | March 2026
Data protection in internal investigations, use of AI in DSARs and recruitment, and deleted data DSAR obligations
Life Sciences and Healthcare
EU overhauls pharmaceutical law with sweeping 2026 reform package
Landmark reform overhauls incentives, supply obligations and regulatory pathways for pharmaceuticals operating in Europe
Life Sciences and Healthcare
Nagoya Protocol compliance shapes EU sourcing of genetic resources for R&D
Life sciences, food and cosmetics businesses using biological materials should assess their exposure to ABS obligations
Financial Services
FCA publishes good and poor practice for UK funds using sustainability labels
The regulator's review of sustainability labelling signals a clear shift from policy setting to active supervision
